Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial

Breast and Ovarian Cancer Risks Due to Inherited Mutations in <i>BRCA1</i> and <i>BRCA2</i>

Mary‐Claire King, Joan H. Marks, Jessica B. Mandell · Science · 2003 · 2.2K citations

Medicine, Genetics, Oncology +17

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

Steven R. Cummings, Stephen Eckert, D Grady et al. · JAMA · 1999 · 1.9K citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham et al. · JNCI Journal of the National Cancer Institute · 2005 · 1.3K citations

Medicine, Oncology, Preventive Medicine +15

Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study Group

Timothy R. Rebbeck, Tara M. Friebel, Henry T. Lynch et al. · Journal of Clinical Oncology · 2004 · 1.1K citations

Medicine, Oncology, Surgery +17

Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a<i>BRCA1</i>or<i>BRCA2</i>Mutation

Hanne Meijers-Heijboer, Bert van Geel, Wim L.J. van Putten et al. · New England Journal of Medicine · 2001 · 963 citations · Full text

Medicine, Oncology, Surgery +12